KOSAN BIOSCIENCES INC 4
4 · KOSAN BIOSCIENCES INC · Filed Jan 4, 2008
Insider Transaction Report
Form 4
Kim Helen Susan
Sr VP, Chief Business Officer
Transactions
- Award
Employee Stock Option
2008-01-03+140,000→ 140,000 totalExercise: $3.54Exp: 2018-01-02→ Common Stock (140,000 underlying) - Award
Restricted Stock Units
2008-01-03+15,100→ 15,100 total→ Common Stock (15,100 underlying)
Footnotes (3)
- [F1]The option vests as follows: 25% of the shares subject to the option vest on 1/03/2009 and 1/48th of the shares subject to the option vest monthly thereafter over a period of 36 months.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the common stock of Kosan Biosciences Incorporated (the "Company").
- [F3]The restricted stock units (the "RSUs") vest as follows: (i) 7,550 RSUs will vest, if at all, if the reporting person remains an employee of the Company through December 31, 2008 and the Company has entered into a written agreement on or before a specified date with a pharmaceutical or biotechnology company for the development and commercialization of a Company-developed Hsp90 inhibitor and/or epothilone product, provided such agreement includes certain minimum financial terms, (ii) 3,775 RSUs will vest, if at all, if the reporting person remains an employee of the Company through December 31, 2009 and (iii) 3,775 RSUs will vest, if at all, if the reporting person remains an employee of the Company through December 31, 2010. In the event that one or more RSUs vest, the Company will deliver to the reporting person one share of the Company's common stock for each RSU that has vested.